Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Neurofilament light chain and glial fibrillary acidic protein as biomarkers of peripheral nervous system involvement in multiple sclerosis: diagnostic and prognostic evaluation.
Activation of the Reverse Cholesterol Transport Pathway: A Strategy to Ameliorate Lipid Metabolic Dyshomeostasis in the Microenvironment Following Spinal Cord Injury.
Pregnancy outcomes in patients with multiple sclerosis with or without exposure to disease-modifying treatment: A retrospective cohort study on Iranian population.
ST8SIA4 and the repair-inflammation axis of lesion remodeling in RRMS.
Exploratory analysis of pupillography-based machine learning for assessing autonomic dysfunction in multiple sclerosis.
Wilson's disease presenting as osmotic demyelination syndrome.
Acute Disseminated Encephalomyelitis Presenting as Fever of Unknown Origin in a 4-Year-Old Boy: A Case Report.
Nutrients and bioactive compounds as modifiers of neurodegenerative trajectories: molecular mechanisms, translational barriers, and precision nutrition.
Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.
Inhibition of Raly promotes oligodendrocyte precursor cell differentiation and remyelination after chronic hypoperfusion.
Temperature effects on TMS-Derived measures of cortical excitability: a systematic review and implications for a warming climate.
Optimizing Rituximab Maintenance Therapy: Outcomes of Extended-Interval Dosing in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.
Co-development of a protocol for a randomised controlled feasibility trial of CIRCuiTS™ cognitive remediation therapy for people with multiple sclerosis.
Prognostic value of neurofilament light chain protein and glial fibrillary acidic protein in multiple sclerosis subtypes and disease activity patterns: a systematic review and meta-analysis.
Correction: A novel cell-free intrathecal approach with PRP for the treatment of spinal cord multiple sclerosis in cats.
Efficacy and Safety of Patients With Relapsing Multiple Sclerosis Switching to Ocrelizumab Due to Suboptimal Treatment Response: Results of the 4-Year CASTING-LIBERTO Trial.
Enhancing Maturation of Human Neuromuscular Organoids via Electrical Stimulation.
Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.
Serum 25-hydroxyvitamin D and neurological disability in multiple sclerosis: a cross-sectional study in a Libyan multicenter cohort.
Data resource profile: PharmaNet, the database for prescription drug dispensing in British Columbia, Canada.
Plasma ECRG4 as a novel diagnostic marker for Alzheimer's disease associated with oligodendrocyte dysfunction.
Virtual brain and electroencephalography explain the variance of memory alterations in mild cognitive impairment.
Oligodendrocyte Piezo2 is a regulator of age-dependent myelin integrity and dysregulated in multiple sclerosis.
Cell-Specific MicroRNA Networks Orchestrate the Pathogenesis of Alzheimer's Disease.
Growth Differentiation Factor 11 Is a Circulating Regulator of Oligodendrocyte Differentiation and CNS Myelin Formation and Repair.
Pages
« first
‹ previous
…
1011
1012
1013
1014
1015
1016
1017
1018
1019
next ›
last »